In this lunch lecture, we take a closer look at how Norway works to prevent cervical cancer, and how the Cervical Screening Programme is an important part of this work. What do we know about the effect of the HPV vaccine? Why is screening still necessary? How close are we really to the goal of eradicating cervical cancer?
You will also get an insight into what happens to the samples after they have been taken, and how bioengineers and doctors in laboratories help to detect cell changes and cancer at an early stage.
In the last part of the lecture, we raise our eyes to the diagnostics of the future and look at how new technology and artificial intelligence can contribute to even better and more accurate cancer prevention.
Program:
Part 1: Can we eradicate cervical cancer?
- HPV and cervical cancer - what is the connection?
- The HPV vaccine and the effect we see today
- The cervical program - how does it work?
- Myths, facts, and frequently asked questions about screening
Part 2: From test to answer
- What happens to the sample in the laboratory?
- How is the cell change detected?
- New technology and artificial intelligence in diagnostics
- Questions and discussion
Practical information
Thelecture will be held on Teams. You will receive a link by e-mail in advance of the lecture. There will be an opportunity to ask questions in the meeting chat. The lecture will be recorded and sent out to registered participants afterwards.
